Trailing in the polls this fall, President Trump dusted off the 2016 campaign playbook and went after the drug companies again. But channeling anger at the companies the whole world is depending on to end the pandemic was always dicey politics. Post-election, the Trump administration hastily issued a final rule setting Medicare Part B reimbursement rates at the lowest levels charged by counties in the developed world, which ration medicines and leave the sick untreated. BIO took the administration to court, and we won when a federal court issued an injunction blocking the rule.
Podden och tillhörande omslagsbild på den här sidan tillhör Biotechnology Innovation Organization. Innehållet i podden är skapat av Biotechnology Innovation Organization och inte av, eller tillsammans med, Poddtoppen.
